Oura GLP-1 Insights: What Oura's New Feature Means for Fitness

Oura GLP-1 Insights is the company's first real move into the GLP-1 space: a new feature inside the Oura App, built for members who take GLP-1 medications.

The idea behind it is that the app knows your dosing schedule and reads your biometric data with that in mind. It does four things: tracks your dose, logs side effects (nausea, fatigue, appetite changes, GI stuff), tracks weight, and pulls all of that into a single view. It'll also remind you to take your medication, whether you're on a weekly one like Zepbound or a daily like Foundayo.

Oura's Advisor, its AI coaching tool, factors your medication in too. If your Readiness Score drops in the two days after a weekly dose, for instance, it can point that out and help you understand why. The feature sits alongside Oura's other metabolic tools, including meal logging, CGM integration, and lab uploads that go live June 30.

For the obvious reasons, Oura is clear that it doesn't prescribe anything, isn't a substitute for your doctor, and that the ring isn't a medical device. GLP-1 Insights starts rolling out in June 2026 to members with a Gen3 ring or newer in the U.S., UAE, and India.

The number Oura leans on is a big one: more than 100 million people on GLP-1s worldwide by 2030. That's the reason a company built around sleep and recovery is suddenly building dose trackers. And it won't be the last. Wearables, apps, clinics, and gyms are all circling the same patients, because people on these medications want help, and they'll take it wherever they can find it. That includes your club.

This is the shift we follow in the Inspire360 GLP-1 Club Intelligence Report. Our Q1 2026 report covered how clubs and solution providers are adapting to the GLP-1 era, and the Q2 edition is on its way with the latest developments. Read Q1 here, and keep an eye out for Q2.

‍